Troy Morrison, DO
Orthopaedic Surgery · Bolivar, MONPI 1073829925
Payments from drug & device makers
Across 87 payments — averaging $387.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Curiteva, Inc.$11K
- Zavation Medical Products, LLC$4K
- Stryker$2K
- Adcura, Inc.$2K
- Augmedics Inc.$324
- plus $801 from 14 others
What the payments were for
- Royalty or licence$10,64832%
- Consulting fees$5,00015%
- Speaking & faculty fees$12,85038%
- Travel & lodging$2,4717%
- Food & beverage$2,7618%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 29 | $14,906 |
| Curiteva, Inc. | 3 | $10,648 |
| Zavation Medical Products, LLC | 2 | $3,500 |
| Stryker | 14 | $1,999 |
| Adcura, Inc. | 5 | $1,552 |
| Augmedics Inc. | 2 | $324 |
| Amgen | 8 | $172 |
| Si-bone, Inc. | 1 | $97 |
| Zimmer Biomet | 1 | $92 |
| Ferring Pharmaceuticals Inc. | 5 | $88 |
| Pacira Pharmaceuticals Incorporated | 2 | $53 |
| Vertex | 3 | $52 |
| Pacira Therapeutics, Inc. | 2 | $51 |
| Titan Surgical Group, LLC | 2 | $50 |
| Globus Medical | 2 | $44 |
| Boston Scientific | 2 | $34 |
| Orthalign Inc | 1 | $19 |
| Innovation Technologies Inc | 1 | $18 |
| Davol Inc. | 1 | $17 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OSTEOCOOL RF ABLATION SYSTEM$14,121
- MAKO$1,751
- Xvision$1,618
- SI Screw System$1,500
- Sagittae$1,500
How this compares
$33,730 in reported general payments places this provider in the 85th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 903 | $23,995 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 274 | $2,564 |
| Gabapentin | 162 | $1,529 |
| Diclofenac Sodium | 120 | $1,403 |
| Meloxicam | 351 | $1,277 |
| Cyclobenzaprine Hcl | 99 | $604 |
| Doxycycline Hyclate | 56 | $376 |
| Tizanidine Hcl | 18 | $345 |
| Cefdinir | 12 | $179 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $129 |
| Prednisone | 39 | $85 |
| Clindamycin Hcl | 48 | $59 |
| Tramadol Hcl | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bolivar
- Matthew SmithColumbia$4M
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Alexandra StrongN Kansas City$1.1M
- Thomas McCormackKansas City$852K
- Michael SnyderJefferson City$676K
- Peter ChalmersSaint Louis$674K
- Paul FrewinSullivan$630K
- Katherine BurnsBridgeton$491K
- Jeremy StattonLees Summit$457K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.